A $20 drug plan jumping to $70 overnight? That’s just the beginning.

Ron Ray breaks down why 2026 could be the most disruptive year yet for Medicare drug plans. From inflation-driven price hikes to the ripple effects of the Inflation Reduction Act, retirees face steep costs if they don’t act during the annual election period. They also explore how annuities purchased in low-interest eras may underperform compared to today’s high-rate options—and why now might be the time to reevaluate. Listeners are urged to consult local experts who understand regional plans and providers before the December 7 deadline.

Learn more about Ron and the teams, as well as schedule a complimentary time to speak with them, by contacting Turning 65 Solutions and Homestead Family Wealth.

See omnystudio.com/listener for privacy information.